ALL |
Acute lymphocytic leukemia |
BL |
Burkitt’s lymphoma |
CASC15 |
Cancer susceptibility candidate 15 |
CLL |
Chronic lymphocytic leukemia |
DDX5 |
DEAD-box RNA helicase |
DLBCL |
Diffuse large B-cell lymphoma |
FLICR |
Foxp3 long intergenic noncoding RNA |
Flatr |
Foxp3-specific lncRNA anticipatory of Tregs |
FL |
Follicular lymphoma |
GAS5 |
Growth arrest-specific 5 |
HSC |
Hematopoietic stem cells |
HOTAIR |
Hox transcript antisense intergenic RNA |
HOTTIP |
HOXA transcript at the distal tip |
HOXA-AS2 |
HOXA cluster antisense RNA 2 |
IFNγ-AS1 |
Interferon gamma antisense RNA 1 |
LncRNAs |
Long non-coding RNAs |
LEF1-AS1 |
Lymphoid enhancer-binding factor 1-antisense RNA 1 |
MALAT1 |
Metastasis associated lung adenocarcinoma transcript 1 |
MEG3 |
Maternally expressed gene 3 |
MYB-AS1 |
MYB antisense RNA 1 |
MIAT |
Myocardial infarction associated transcript |
MCL |
Mantle-cell lymphoma |
mTOR |
Mammalian target of rapamycin |
NcRNAs |
Non-coding RNAs |
NK cell |
Natural killer cell |
NEAT1 |
Nuclear enriched abundant transcript 1 |
NHL |
Non-Hodgkin lymphoma |
NKTCL |
Natural killer/T-cell lymphoma |
PAIR |
PAX5-activated intergenic repeat |
PANDA |
P21-associated ncRNA DNA damage-activated |
PRC2 |
Polycomb repressive complex 2 |
PI3K |
Phosphatidylinositol 3-kinase |
PiRNAs |
PIWI-interacting RNAs |
RNASeq |
RNA-sequencing |
RT-PCR |
Reverse transcription polymerase chain reaction |
SncRNAs |
Small non-coding RNAs |
SiRNAs |
Small interfering RNAs |
SMAD1-AS1 |
SMAD1 antisense RNA 1 |
ShRNA |
Short hairpin RNA |
XIST |
X-inactive specific transcript |